To The Moon

On April 14 and 15, 2026, AE RED HOLDINGS, LLC, a director and 10% owner of Redwire Corp (Ticker: RDW), sold a total of 1,895,311 shares of common stock. The shares were sold at prices ranging from...

cathie-wood-buys-tesla-tsla-dip-11-million-amid-warning-from-analyst

Intel (INTC.US) has appointed a new chief architect to spearhead its graphics processing unit (GPU) operations, CEO Patrick Gelsinger announced on Tuesday. He also indicated that the ongoing memory...

Ondas Inc., through its subsidiary American Robotics, has achieved a significant milestone as its Optimus drone was granted Blue List status by the Defense Contract Management Agency . This designation places the Optimus drone within the Department of War's approved directory for secure, NDAA-compliant commercial unmanned aircraft systems. The approval confirms that American Robotics’ Optimus drone meets rigorous standards for cybersecurity, supply-chain integrity, and operational reliability, further positioning Ondas Inc. for expanded deployment in defense and critical infrastructure applications.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ondas Inc. published the original content used to generate this news brief via ACCESS Newsw

$Redwire(RDW)$ announced Tuesday it has been awarded a position on the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD)...

Microbot Medical Inc. announced that Emory University Hospital has become the first hospital in the world to adopt the LIBERTY Endovascular Robotic System for patient care. The hospital will use the system in its interventional radiology program and collaborate with Microbot to establish an Endovascular Robotics Program. The LIBERTY system is FDA cleared, single-use, and remotely operated, designed for peripheral endovascular procedures. This adoption follows the company's recent limited market release of the system and plans for a full market release in April 2026.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire on November 26, 2025

$Tesla(TSLA)$ bulls see the company as a kind of tech conglomerate, making self-driving cars and energy storage systems, operating a large network of fast chargers in the U.S., and a small network of...

Citi raised the firm’s price target on Opendoor Technologies (OPEN) to $1.40 from 70c and keeps a Sell rating on the shares post the Q3 report. The...